Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.65 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.65 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.65 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.65 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.59 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.59 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.57 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4817193 | 0.94 | CHRM2 (0.63) | CHRM2CHRM1CHRM3TAAR1MTNR1A | |
| SCHEMBL3297777 | 0.93 | PPARG (0.61) | CHRM2CHRM1CHRM3TAAR1MTNR1A | |
| SCHEMBL8956379 | 0.93 | PPARG (0.61) | CHRM2CHRM1CHRM3TAAR1MTNR1A | |
| SCHEMBL10534527 | 0.93 | PPARG (0.61) | CHRM2CHRM1CHRM3TAAR1MTNR1A | |
| SCHEMBL9796229 | 0.93 | PPARG (0.61) | CHRM2CHRM1CHRM3TAAR1MTNR1A | |
| SCHEMBL9747684 | 0.93 | PPARG (0.61) | CHRM2CHRM1CHRM3TAAR1MTNR1A | |
| SCHEMBL17509808 | 0.93 | PPARG (0.61) | CHRM2CHRM1CHRM3TAAR1MTNR1A | |
| SCHEMBL3477833 | 0.93 | PPARG (0.61) | CHRM2CHRM1CHRM3TAAR1MTNR1A | |
| SCHEMBL21002016 | 0.90 | TAAR1 (0.71) | CHRM2CHRM1CHRM3TAAR1MTNR1A | |
| SCHEMBL21002162 | 0.90 | TAAR1 (0.71) | CHRM2CHRM1CHRM3TAAR1MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426115-B2 | Patterning process and resist composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-04-23 | — | — | US | claimed |
| US-20110033803-A1 | PATTERNING PROCESS AND RESIST COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-02-10 | — | — | US | claimed |
| US-20100159392-A1 | PATTERNING PROCESS AND RESIST COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-06-24 | — | — | US | claimed |
| US-4473713-A | Hydrolysis of aryl-aliphatic ethers | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-09-25 | — | — | US | claimed |
| CN-114317448-B | Hybridoma cell strain secreting anti-etoxazole monoclonal antibody and application thereof | 无锡迪腾敏生物科技有限公司 | 2023-11-28 | — | — | CN | disclosed |
| US-20230219912-A1 | HALOGENATED BENZOTHIADIAZINES FOR THE TREATMENT OF CANCER | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-07-13 | — | — | US | disclosed |
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | ENODIA THERAPEUTICS SAS (FR) | 2022-05-19 | — | — | US | disclosed |
| US-11248009-B2 | Polycyclic aromatic compound, material for an organic device, organic electroluminescent element, display apparatus and lighting apparatus | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2022-02-15 | — | — | US | disclosed |
| WO-2021226465-A1 | GLUCOCORTICOID RECEPTOR MODULATORS | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2021-11-11 | — | — | WO | disclosed |
| EP-2694437-B1 | PROCESS FOR PRODUCING ACYLATION CATALYST | BASF SE (DE) | 2020-10-21 | — | — | EP | disclosed |
| US-20200207787-A1 | POLYCYCLIC AROMATIC COMPOUND, MATERIAL FOR AN ORGANIC DEVICE, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY APPARATUS AND LIGHTING APPARATUS | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2020-07-02 | — | — | US | disclosed |
| WO-2020045681-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT USING LIGHT EMITTING MATERIAL COMPOSED OF POLYCYCLIC AROMATIC COMPOUND | 学校法人関西学院 | 2020-03-05 | — | — | WO | disclosed |
| WO-1996037452-A1 | METHOD FOR HYDROXYALKYLATING A CARBOCYCLIC AROMATIC ETHER | RHONE-POULENC CHIMIE (FR) | 1996-11-28 | — | — | WO | disclosed |
| WO-1996035655-A1 | AROMATIC ETHER ACYLATION PROCESS | RHONE-POULENC CHIMIE (FR) | 1996-11-14 | — | — | WO | disclosed |
| WO-1996035656-A1 | AROMATIC ETHER ACYLATION PROCESS | RHONE-POULENC CHIMIE (FR) | 1996-11-14 | — | — | WO | disclosed |
| WO-1996021637-A1 | PROCESS FACILITATING THE REGENERATION OF A ZEOLITHE-BASED CATALYST IMPLEMENTED IN AN ACYLATION REACTION, CATALYST AND UTILIZATION | RHONE-POULENC CHIMIE (FR) | 1996-07-18 | — | — | WO | disclosed |
| EP-0698593-A1 | Process for the acylation of an aromatic compound | RHONE-POULENC CHIMIE (FR) | 1996-02-28 | — | — | EP | disclosed |
| US-4837301-A | FROM ALKALI MTEAL SULFIDES AND AROMATIC DIHALOGEN COMPOUNDS; IMPROVED CORROSION RESISTANCE | BAYER AKTIENGESELLSCHAFT (DE) | 1989-06-06 | — | — | US | disclosed |
| EP-0275007-A2 | Process for the preparation of highly molecular, optionally branched polyarylene sulfides | BAYER AG (DE) | 1988-07-20 | — | — | EP | disclosed |
| US-4473713-A | Hydrolysis of aryl-aliphatic ethers | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11248009-B2 | Polycyclic aromatic compound, material for an organic device, organic electroluminescent element, display apparatus and lighting apparatus | TYR, AOC2, AOC1 | CHRM2 2642/4885CHRM1 2584/4885CHRM3 2835/4885 |
| US-20230219912-A1 | HALOGENATED BENZOTHIADIAZINES FOR THE TREATMENT OF CANCER | TFAM, NDUFAF1, NDUFV1 | CHRM2 4715/4885CHRM1 4703/4885CHRM3 4564/4885 |
| US-20200207787-A1 | POLYCYCLIC AROMATIC COMPOUND, MATERIAL FOR AN ORGANIC DEVICE, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY APPARATUS AND LIGHTING APPARATUS | TYR, AOC2, AOC1 | CHRM2 2642/4885CHRM1 2584/4885CHRM3 2835/4885 |
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | SEC61B, SEC61A1, SEC61G | CHRM2 4839/4885CHRM1 4824/4885CHRM3 4775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.